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Figure S1. DN3a Thymocytes Upregulate CD27 upon OP9-DL1 Culture 
FACS analysis of DN3a thymocytes from C57BL/6 mice before and after 3 days of OP9 
culture. Dot plots show CD44 and CD25 stainings. Histograms show intensities of CD27 
expression in the corresponding populations. Data shown are representative of three 
independent experiments. 
 
   
Figure S2. Only TCR-δ+ Descendants of DN3a Cells Survive in the Absence of DL1 
(A) Total number of cells in OP9-control cultures initiated with 5000 C57BL/6 DN3a 
thymocytes after 3 and 7 days of culture.  
(B) FACS analysis of cells described in (A) after 7 days of OP9-control culture.  
 
 
Figure S3. Alternative Methods to Identify DN3b Thymocytes 
FACS analysis of CD3 and CD8 depleted C57BL/6 thymocytes. Dot plots show two 
independent experiments (Exp1, top row and Exp2, bottom row) with two different 
gating strategies (A and B) as compared to Figure 1 of the manuscript to identify DN3b 
thymocytes (red gates).  
(A) Depleted thymocytes were initially gated on CD25+ cells as shown in histograms and 
then analyzed for CD44 and CD27 expression.  
(B) Depleted thymocytes were gated on DN3 thymocytes based on CD44 and CD25 
expression and then further analyzed based on FSC and CD27 expression. 
Additional hints: 
The frequency of DN3b thymocytes seems to depend on the age of the animals and may 
decrease with aging. Also very important is the use of the CD27 antibody to get optimal 
separation of CD27low and CD27high DN3 thymocytes. We recommend using CD27-PE 
and search for optimal settings by changing the FL2 PMT to get the best resolution.
Table S1. Primer Sequences 
Notch1 forward CCACTGTGAACTGCCCTATGT 
Notch1 reverse TTGTTTCCTGGACAGTCATCC 
Notch 3 forward AGGGAGATGCAGATGCAGAC 
Notch 3 reverse GAAGGAGGCCAGCATAAGTG 
Runx1 forward CTCGGCAGAACTGAGAAATG 
Runx1 reverse GACGGTGATGGTCAGAGTGA 
Runx3 forward GGTTCAACGACCTTCGATTC 
Runx3 reverse GGTCCATCCACAGTGACCTT 
Gfi1 forward CTCATTCCTGGTCAAGAGCAA 
Gfi1 reverse GAGCCTCGGTAAGCTGAGAGT 
Gfi1B forward GAGATGTTGCTGAACCAGAGC 
Gfi1B reverse TGTAGGAGGAGGCCAAGGTAT 
Herp1 forward GAAGCGCCCTTGTGAGGAA 
Herp1 reverse TGTCGGTGAATTGGACCTCAT 
Mybl2 forward AAGGAGGTGCTCCGTTCTGA 
Mybl2 reverse CCAGAGACTTGCGGACCTTCT 
Egr2 forward CAGACTCAGCCTGAACTGGAC 
Egr2 reverse AGAATGCTGAAGGATCCTGGT 
Egr3 forward CTCGGTAGCCCATTACAATCA 
Egr3 reverse GCGAACTTTCCCAAGTAGGTC 
Id3 forward AGAGGAGCTTTTGCCACTGA 
Id3 reverse TGGAGAGAGGGTCCCAGAGT 
 
 
Table S2. Ratios of TCR-δ+ T Cell Generation on OP9-DL1/OP9-Control Stromal Cells 
 
DN3 Subset TCR-δ+ Ratio on OP9-DL1/OP9-Control Stromal Cells 
C57BL/6 DN3a 2.46 (± 1.97) 
TCR-β-/- DN3a 2.19 (± 0.24) 
C57BL/6 DN3b 1.40 (± 1.03) 
TCR-β-/- DN3b 1.12 (± 1.14) 
 
